Clinical considerations of the role of palbociclib in the management of advanced breast cancer patients with and without visceral metastases.

Document types check

Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.12530/38116

Title:	Clinical considerations of the role of palbociclib in the management of advanced breast cancer patients with and without visceral metastases.
Authors:	Turner, N C Finn, R S Martin, M Im, S-A DeMichele, A Ettl, J Diéras, V Moulder, S Lipatov, O Colleoni, M Cristofanilli, M Lu, D R Mori, A Giorgetti, C Iyer, S Bartlett, C Huang Gelmon, K A View more
Mesh:	Adult Aged Aged, 80 and over Antineoplastic Agents, Hormonal Antineoplastic Combined Chemotherapy Protocols Breast Neoplasms Female Fulvestrant Humans Letrozole Middle Aged Neoplasm Metastasis Piperazines Progression-Free Survival Pyridines Quality of Life Viscera View more
Issue Date:	2018
Citation:	Ann. Oncol..2018 03;(29)3:669-680
Abstract:	This report assesses the efficacy and safety of palbociclib plus endocrine therapy (ET) in women with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer (ABC) with or without visceral metastases.
PMID:	29342248
URI:	https://hdl.handle.net/20.500.12530/38116
Rights:	openAccess
Appears in Collections:	Fundaciones e Institutos de Investigación > IIS H. General U. Gregorio Marañón > Artículos

Files in This Item:

File	Description	Size	Format
PMC5888946.pdf		576.97 kB	Adobe PDF	View/Open